The majority of pharmaceutical development for COVID-19 has been aimed at vaccines. However, a recent Interesting Engineering article discussed a new pill that treats people once they’ve contracted the virus. The drug is called molnupiravir, and its five-day regimen successfully reduced hospitalizations and deaths linked to COVID-19 by half. If approved for emergency use, the drug, developed by Merck, will be the first oral treatment for the illness and could be a step toward eradicating the pandemic.
New Pill Hopes to Fight COVID-19
Merck & Co. has a new pill that allegedly cuts coronavirus hospitalizations and deaths in half.
Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Unlock Learning Here
Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Take Quiz
